West Georgia resident Ella Velez, 15, is among the first pediatric patients in the world to receive the medication, according to a May 23 news release from Atlanta-based Piedmont Healthcare. With the help of endocrinologist Steven Leichter, MD, Ella received infusions for 14 days.
Piedmont Columbus Regional is the first hospital in the U.S. to develop a screening process for patients who might be candidates for Tzield, the release said. In fall 2024, the 24-hospital system will open a children’s hospital that will have the capability to offer the medication to more patients.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
